# US 2025/0378918 A1 · Phenotype-Based Chemical Screens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0378918 A1
- Document ID: US20250378918A1
- Status: Published application
- Kind: A1
- Application number: 19/031,991
- Filed: 2025-01-18
- Published: 2025-12-11
- Earliest claimed: 2015-12-14
- Assignees: NemaMetrix Inc.; The General Hospital Corportation, dba Massachusetts General Hospital
- Applicants: Nemametrix; The General Hospital Corportation, dba Massachusetts General Hospital
- Inventors: David Kokel; Randall T. Peterson; Giancarlo Bruni; Andrea Velenich
- Web page: https://patentgrep.com/patent/US20250378918A1

## CPC

- G16B 50/30: Data warehousing; Computing architectures
- A61K 31/4965: Non-condensed pyrazines
- A61K 49/0008: {Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure}
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 50/00: ICT programming tools or database systems specially adapted for bioinformatics
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 50/10: Ontologies; Annotations
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Embodiments of the present invention provide materials and methods for performing phenotype-based chemical screens. Embodiments disclosed herein pertain to the use of a battery of high-throughput zebrafish behavioral assays to generate behavioral profiles. In accordance with these embodiments, responses to various chemical compounds with known and unknown biological functions can be used to generate behavioral profiles. Embodiments also involve generating behavioral profiles based on genetic mutations or environmental perturbations. Establishing databases of behavioral profiles facilitates identification of novel chemicals that phenocopy effects of therapeutic agents and/or that modulate genetic or environmental behavioral profiles, thereby providing a basis for not only assessing the properties of known chemical compounds but also for developing novel treatments for human diseases.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

A method for screening chemical compounds based on behavioral phenotypes, comprising:
generating a behavioral phenotype profile from a battery of at least ten phenotype assays with zebrafish administered a reference compound;
administering one or more of the chemical compounds to zebrafish and performing the at least ten phenotype assays;
identifying compounds with same or similar phenotype profile as the reference compound, whereby chemical compounds are screened and identified with same or similar in vivo activity as the reference compound.

### Claim 23 (depends on 22)

The method of claim 22, wherein the behavioral phenotype profile is generated via presentation of one or more stimuli to the zebrafish.

### Claim 24 (depends on 23)

The method of claim 23, wherein the one or more stimuli comprises one or more of light, sound, vibration, visual patterns, and electrical shocks.

### Claim 25 (depends on 22)

The method of claim 22, wherein the chemical compound has psychoactive properties.

### Claim 26 (depends on 22)

The method of claim 22, wherein the method is performed as part of an automated high-throughput screening platform further comprising storing the behavioral phenotype profile in a database.

### Claim 27 (depends on 26)

The method of claim 26, wherein the automated high-throughput screening platform comprises software that synchronizes image acquisition when subjecting the zebrafish to the behavioral assays and extracts behavioral data when obtaining the behavioral phenotype profile.

### Claim 28

A system for performing a high-throughput screen for chemical compounds, the system comprising:
a population of zebrafish exposed to the chemical compound;
a digital video camera capable of capturing and storing images;
a mechanism configured for presenting one or more stimuli to the population of zebrafish; and,
software that synchronizes capturing and storing of images when subjecting the population of zebrafish to ten or more behavioral phenotype assays to generate a behavioral phenotype profile, and wherein the software extracts behavioral data from the ten or more behavioral phenotype assays to generate the behavioral phenotype profile.

### Claim 29 (depends on 28)

The system of claim 28, further comprising a mechanism for exposing the population of zebrafish to the chemical compounds.

### Claim 30 (depends on 28)

The system of claim 28, wherein the one or more stimuli comprises one or more of light, sound, vibration, visual patterns, and electrical shocks.

### Claim 31 (depends on 28)

The system of claim 28, wherein the one or more stimuli comprises light at wavelengths of at least 405 nanometers, 450 nanometers, or 660 nanometers.

### Claim 32 (depends on 28)

The system of claim 28, wherein the chemical compound has psychoactive properties.
